MediChem Signs Agreements and Acquisitions
Source: Medichem Research Inc.
MediChem has signed an agreement with Argonne National Laboratory, and has acquired Emerald BioStructures, Inc. and ThermoGen, Inc. The proprietary user agreement with Argonne, grants the company access to its APS. The use of the high brilliance X-ray beam allows for high speed data collection leading to rapid protein structure determination.
The acquisition of Emerald BioStructures, Inc. will give access to their crystallization technology, which, when coupled with access to Argonne's APS, allows structural information about target proteins and other macromolecules to accelerate the discovery and development of new drug candidates.
By acquiring ThermoGen, Inc., MediChem gains access to their biocatalysis technology. Their process improves chemical processes for the scale-up and manufacturing of pharmaceutical products.
Medichem Research Inc, 12305 S. New Avenue, Lemont, IL 60439, Tel: 888-650-CHEM, Fax: 630-257-1505
This website uses cookies to ensure you get the best experience on our website. Learn more